The Brexit Health Alliance (BHA), which brings together the NHS, medical research, industry, patients and public health organisations, has urged for regulatory arrangements to be made as a matter of urgency to prevent any potential risk to public health as a result of Brexit.
Brexit relations
In its briefing, released today (29 January), the BHA has summarised the potential impact Brexit may have on patient access to medicines and medical devices and released what it would like to see happen to ensure patients are not negatively affected.